menu search

Thrombectomy devices market value to surpass us$ 3.4 bn by 2031, as per tmr report

The rise in prevalence of cardiac disorders globally is anticipated to create lucrative opportunities i...

March 3, 2023, 5:30 am

Bioabsorbable stents market to exceed us$ 560.1 mn by 2031: tmr study

Significant utilization of bioabsorbable polymer-based stents, particularly to treat coronary artery diseases, is expected to offer substantial opport...

March 2, 2023, 11:30 pm

cardiff oncology (crdf) reports q4 loss, tops revenue estimates

cardiff Oncology (CRDF) delivered earnings and revenue surprises of 20% and 70.67%, respectively, for t...

March 2, 2023, 9:04 pm

Lightning round: cardinal health is a very good stock to own here

Mad Money host Jim Cramer weighs in on all manner of stocks, including CyberArk, Snowflake, cardinal He...

March 1, 2023, 8:09 pm

Is trending stock cardinal health, inc. (cah) a buy now?

cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth explo...

February 28, 2023, 10:33 am

Dream-hf phase 3 trial results for mesoblast cell therapy in heart failure published in journal of the american college of cardiology (jacc)

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced publication of the...

February 27, 2023, 11:29 pm

Windtree announces istaroxime scientific abstract has been accepted at the 2023 technology and heart failure therapeutics conference

WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...

February 27, 2023, 1:00 pm

cardiff oncology to present at the cowen 43rd annual health care conference

SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biote...

February 27, 2023, 8:15 am

Merit medical: reasonably-priced execution, with m&a upside

Merit Medical delivered a modestly better than expected fourth quarter, with a little upside on revenue and a $0.02/share beat at the operating income...

February 25, 2023, 1:53 am

Cytosorbents to report fiscal 2022 operating and financial results

MONMOUTH JUNCTION, N.J. , Feb. 24, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condit...

February 24, 2023, 7:00 am

Merit medical (mmsi) q4 earnings top estimates, margins down

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its cardiovascular segment...

February 23, 2023, 12:03 pm

Energy recovery, inc. (erii) q4 2022 earnings call transcript

Energy Recovery, Inc. (NASDAQ:ERII ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Jim Sic...

February 22, 2023, 11:12 pm

cardinal health: downgrading due to absence of safety margin (rating downgrade)

cardinal Health, Inc.'s consistent fundamentals and growth prospects were reinforced by Q2 2023 earning...

February 21, 2023, 3:13 pm

Medtronic plc (mdt) q3 2023 earnings call transcript

Medtronic plc (NYSE:MDT ) Q3 2023 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Ryan Weispfenning - Investor Relations Ge...

February 21, 2023, 12:29 pm

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

Medtronic tops third-quarter estimates as revenue boosted by strong cardiovascular and neuroscience portfolios

Medtronic Plc stock MDT, +0.71% rose in premarket trade Tuesday, after the medical device maker beat fiscal third-quarter consensus estimates. The Dub...

February 21, 2023, 6:56 am

Merck to present new data for sotatercept and mk-0616 at acc.23/wcc, demonstrating significant progress in advancing its innovative cardiovascular pipeline

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present New Data for Sotatercept and MK-0616 at ACC....

February 21, 2023, 6:45 am

Warren buffett just broke 1 of his cardinal rules

Buffett's company Berkshire Hathaway is known as a long-term investor. But it didn't stick to this rule in the fourth quarter of 2022....

February 19, 2023, 7:23 am


Search within

Pages Search Results: